Bio Green Med Solution (BGMS) vs Dermata Therapeutics (DRMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bio Green Med Solution is the larger company by market cap ($5.6 million vs $5.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BGMS | DRMA |
|---|---|---|
| Share price | $0.8399 | $1.07 |
| Market cap | $5.56M | $5.30M |
| 1-day change | -1.19% | -4.46% |
| EPS (TTM) | $-5.02 | $-4.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.70 | $4.84 |
| 52-week low | $0.57 | $0.951 |
| Distance from 52-week high | -87.46% | -77.89% |
| Average volume | 74.44K | 708.18K |
| Shares outstanding | 6.62M | 4.96M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BGMS vs DRMA FAQ
Which is bigger, Bio Green Med Solution or Dermata Therapeutics?
Bio Green Med Solution (BGMS) is larger, with a market capitalization of $5.56M compared with $5.30M for Dermata Therapeutics (DRMA).
Are Bio Green Med Solution and Dermata Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.